News & Updates

Home-monitoring vision tests appear to have insufficient accuracy for detecting active neovascular age-related macular degeneration (nAMD), according to a study.

Densiron, a heavier-than-water endotamponade agent, may be used in the treatment of primary rhegmatogenous retinal detachment (RRD) in eyes with predominantly inferior retinal pathology and proliferative vitreoretinopathy (PVR) grade C, as shown by its higher anatomic success rates and improved visual outcomes relative to conventional light silicone oil (LSO), suggests a study.

The use of melatonin appears to exert some protective effect on the risk of age-related macular degeneration (AMD) incidence and progression, as suggested in a retrospective cohort study.

New drug applications approved by US FDA as of 16-31 May 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Remote consultation using point-of-care automated optical coherence tomography (OCT) is feasible in the diagnosis of retinal artery occlusion, suggests a study.

The 100-week results of the phase III KESTREL and KITE studies reflect the long-term efficacy and durability of brolucizumab in improving visual and anatomical outcomes in patients with diabetic macular oedema (DMO).

Vision-related quality of life (VR-QoL) in patients with glaucoma who underwent trabeculectomy remains unchanged before and after the procedure, which indicates the stabilizing effect of trabeculectomy on both objective and subjective visual function, according to a study.